Firms
Theme

CLS

Celestica, Inc. · NYSE

$260.01USDCS band Mixed

↓ $9.00 (3.35%)

Last close · Oct 23, 4:00 PM ET

Sign up free to see this.

Mkt Cap
$32.8B
Volume
129.2K
52W High
$474.03
52W Low
$244.51
PE Ratio
29.4
Avg Vol
2.2M
As of 10/23/26
Div Yield
—
Beta
3.35
As of 10/23/26

Analysts

All ›

Targets are shown as reported, adjusted only for stock splits, not as predictions. Not investment advice.

Sentiment

No sentiment yet

At least 5 tagged posts are needed.

How do you feel about CLS?

Latest news

News ›

Zacks Investment Research

Is Trending Stock Celestica, Inc. (CLS) a Buy Now?

Celestica (CLS), an electronics manufacturing services company, has declined 15.8% over the past month while the broader market gained 0.7%. Despite strong fundamentals including 90.5% year-over-year earnings growth for the current quarter and consistent beats on both earnings and revenue estimates, the stock received a Zacks Rank #3 (Hold) rating. The company is valued at par with peers and is expected to perform in line with the broader market in the near term.

Zacks Investment Research

Celestica (CLS) Stock Dips While Market Gains: Key Facts

Celestica (CLS) closed down 1.14% and is expected to report earnings on October 26, 2026, with projected EPS of $3.01 (up 90.51% YoY) and revenue of $5.4 billion (up 69.1% YoY). The company holds a Zacks Rank #3 (Hold) rating with a Forward P/E of 26.83, trading at a premium to its industry average of 22.9. The Electronics - Manufacturing Services industry ranks #17 among all industries.

Zacks Investment Research

Celestica vs. SpaceX: Which Aerospace Stock is the Better Buy Now?

SpaceX (SPCX) emerges as the better investment pick compared to Celestica (CLS), driven by stronger price performance, significant upward earnings revisions (350% over 60 days), and a higher Zacks Rank #2 (Buy). While CLS offers more attractive valuation metrics with lower price-to-sales ratio, SPCX's projected 136.2% sales growth in 2026 and commanding market position in commercial launches outweigh valuation concerns. However, SPCX faces margin uncertainty due to heavy capital investments in AI infrastructure initiatives.

Headlines link to the publisher. Not investment advice.

Board · 0 threads

Open board ›

No threads yet

Community posts are member opinions. Desk posts are automated weekly counts. Not investment advice.

Analysts

All ›

Targets are shown as reported, adjusted only for stock splits, not as predictions. Not investment advice.

Community

7 days

No sentiment yet

Posts 24h
0
Replies 24h
0
Watchers
0

Board · $CLS · 0 threads

Sign in to post on $CLS

No threads yet

Community posts are member opinions. Desk posts are automated weekly counts. Not investment advice.

Cylvex is a financial simulation and community platform designed for educational and informational purposes only. Market data may be delayed. Nothing on this platform constitutes investment advice, financial advice, trading advice, or any other sort of advice. You should not treat any of the platform's content as such. Cylvex does not recommend that any financial instrument should be bought, sold, or held by you. Do conduct your own due diligence and consult your financial advisor before making any investment decisions. By using Cylvex, you acknowledge that you are using the platform at your own risk.

Terms · Privacy · Disclaimer · Methodology · Logos provided by Logo.dev